Competitive Technologies announces technology marketing agreements with three leading British universities.

WESTPORT, Conn--(BUSINESS WIRE)--Sept. 17, 1996--Competitive Technologies Inc. (ASE: CTT), a major U.S. technology company concentrating primarily on the commercialization and licensing of high technology research, has signed service and representation agreements with Newcastle University Ventures (NuVentures), Brunel University and The University of Edinburgh, three leading incubators of new technology in the United Kingdom.

George M. Stadler, president and CEO of CTT, said that his company is already evaluating several interesting biotechnology inventions developed at the institutions. "We are also discussing agreements with several more UK and European universities at this time," he noted.

"Competitive Technologies' mission is to help these institutions expand the markets for their science and inventions in North America and the Far East," Stadler commented.

CTT already has an agreement with The Technical University of Hamburgh (Germany) for exclusive North American licensing of an innovative technique for the use of precision ceramics in auto parts and tools.

Professor Hamnett, chairman of NuVentures, said, "We are delighted at the opportunity of working with CTT to extend our technology transfer activities in a focused way to North America and worldwide."

Head of Brunel University's Research Services Bureau, Christine A. Macfarlane, said, "Brunal University in West London is a modern forward-looking university, and places great value on its applied research as well as its pure investigative research. It has a well established reputation as a center of excellence in a number of scientific areas including, molecular biology of cancer, environmental pollution on aquatic organisms, and, on the engineering side, in the development and exploitation of injection molding and extrusion technology and the development of materials for bioengineering applications, including some for potential use as artificial heart components, performed in association with Sir Magdi Yacoub, the internationally renowned heart specialist. We see our relationship with CTT enabling us to develop further our international links and extend our industrial outreach program."

Dr. Keith Winton, deputy director of industrial liaison for the University of Edinburgh, added, "The University of Edinburgh is one of the top five in the UK with an annual research budget in excess of $75 million, putting it ahead of many important commercial companies. However, we have always been restricted in our ability to bring our new technologies to the world's largest marketplace through lack of pressence in the U.S. Our new link with CTT addresses that problem and we are confidant that we will be able to better realize the potential of much of the state of the art work in which we are presently engaged."

CTT is also developing its program for working with UK research institutes, building upon the relationship initiated last year with the Babraham Institute, Cambridge, UK. Dr. James S. Green, vice president responsible for liaison with European research institutes said, "We identified Babraham as one of the leading UK research centers in modern integrative biotechnology and were impressed by the vision of the Director, Dr. Richard Dyer, for progressing strategic research programs focused upon cell signaling, recognition mechanisms and development which involve functional exploration of the genome. The work at Babraham is generating platform technologies for biotechnology and pharmaceutical industries."

CTT will continue to strengthen its links with European research organizations assisting them to expand the market for their scientific expertise and inventions in North America and the Far East, and creating productive collaboration with industry which will increase the flow of R&D funds into those research institutions and universities.

Competitive Technologies Inc. -- based in Westport, with offices in Bethlehem, Pa; Cleveland; Osaka, Japan; and London -- is in the technology transfer business concentrating primarily on the commercialization and licensing of high-tech company and university research. CTT has evaluated over 8,000 technologies, been responsible for closing several hundred license agreements, and helped launch 15 new companies. CTT also has been awarded a number of collaborative R&D contracts involving partnerships between university, industry and federal/state governments. Additional information about CTT can be found on its web-site: WWW.CTI.Lehigh.edu.

CONTACT: Competitive Technologies, Inc., Westport

George M. Stadler, 203/255-6044

Fax: [phone]

or

Dr. James Green, 216/586-2090

Fax: [phone]